114 related articles for article (PubMed ID: 8389736)
21. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
[TBL] [Abstract][Full Text] [Related]
22. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.
Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G
Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491
[TBL] [Abstract][Full Text] [Related]
23. [Pathological examination for liver transplantation].
Nakayama J; Ota H; Katsuyama T; Nakazawa Y; Hashikura Y; Kawasaki S
Rinsho Byori; 2000 Nov; 48(11):1022-8. PubMed ID: 11132555
[TBL] [Abstract][Full Text] [Related]
24. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL
Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778
[TBL] [Abstract][Full Text] [Related]
25. Factors increasing the risk of allograft vascular disease in heart transplant recipients.
Arbustini E; Dal Bello B; Morbini P; Klersy C; Grasso M; Diegoli M; Gavazzi A; Campana C; Grossi P; Pellegrini C; Martinelli L; Ippoliti G; Specchia G; Viganò M
G Ital Cardiol; 1997 Oct; 27(10):985-99. PubMed ID: 9359048
[TBL] [Abstract][Full Text] [Related]
26. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
27. Incidence, timing, and risk factors for acute and chronic rejection.
Neuberger J
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S30-6. PubMed ID: 10431015
[TBL] [Abstract][Full Text] [Related]
28. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
29. Chronic allograft nephropathy.
Najafian B; Kasiske BL
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
[TBL] [Abstract][Full Text] [Related]
30. [Cytomegalovirus infection and allograft rejection].
Humbert M; Emilie D
Rev Mal Respir; 1996 Nov; 13(5 Suppl):S85-91. PubMed ID: 9011915
[TBL] [Abstract][Full Text] [Related]
31. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection.
Demirhan B; Bilezikçi B; Haberal AN; Sevmiş S; Arat Z; Haberal M
Liver Transpl; 2008 Feb; 14(2):214-9. PubMed ID: 18236397
[TBL] [Abstract][Full Text] [Related]
32. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts.
Neil DA; Hubscher SG
Hepatology; 2002 Mar; 35(3):639-51. PubMed ID: 11870379
[TBL] [Abstract][Full Text] [Related]
33. Chronic rejection of small bowel grafts: pediatric and adult study of risk factors and morphologic progression.
Parizhskaya M; Redondo C; Demetris A; Jaffe R; Reyes J; Ruppert K; Martin L; Abu-Elmagd K
Pediatr Dev Pathol; 2003; 6(3):240-50. PubMed ID: 12658538
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: reliability of the 1999 Banff schema.
Sebagh M; Blakolmer K; Falissard B; Roche B; Emile JF; Bismuth H; Samuel D; Reynès M
Hepatology; 2002 Jan; 35(1):117-25. PubMed ID: 11786967
[TBL] [Abstract][Full Text] [Related]
35. Immunologic sensitization in recipients of left ventricular assist devices.
John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
[TBL] [Abstract][Full Text] [Related]
37. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
[TBL] [Abstract][Full Text] [Related]
39. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
[TBL] [Abstract][Full Text] [Related]
40. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
